BTCC / BTCC Square / Global Cryptocurrency /
10X Genomics (TXG) Stock Rises 4% on Cleveland Clinic Bladder Cancer Collaboration

10X Genomics (TXG) Stock Rises 4% on Cleveland Clinic Bladder Cancer Collaboration

Global Cryptocurrency
Release Time:
2026-06-18 02:24:02
0
BTCCSquare news:

10X Genomics shares gained 3.8% following news of a multi-year research partnership with Cleveland Clinic focused on bladder cancer biomarkers. The collaboration will leverage TXG's single-cell analysis platforms to study tumor microenvironment responses to emerging antibody-drug conjugate therapies.

While insiders have sold $1.8 million in shares recently, the market reacted positively to the potential long-term implications of this academic-commercial partnership in precision oncology.

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users